Achillion Pharmaceuticals (ACHN) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Join SI Premium – FREE
Achillion Pharmaceuticals (NASDAQ: ACHN) reported Q2 EPS of ($0.25), $0.07 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Achillion Pharmaceuticals (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Victoria’s Secret shares slump 16% on weak Q3 operating income outlook
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
